|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [ABCC5 protein results in decreased susceptibility to Fluorouracil]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [ABCC5 protein results in decreased susceptibility to Thioguanine] |
CTD |
PMID:15897250 |
|
NCBI chr11:84,395,982...84,490,215
Ensembl chr11:84,396,033...84,490,211
|
|
G |
Ano6 |
anoctamin 6 |
decreases activity |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of ANO6 protein |
CTD |
PMID:24478309 |
|
NCBI chr 7:137,142,063...137,335,208
Ensembl chr 7:137,142,170...137,335,208
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid promotes the reaction [VIP protein results in increased expression of AQP3 mRNA] |
CTD |
PMID:12542607 |
|
NCBI chr 5:57,423,735...57,429,252
Ensembl chr 5:57,423,734...57,429,245
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [TNF protein promotes the reaction [MAPK1 protein results in increased phosphorylation of ATF2 protein]] |
CTD |
PMID:9918806 |
|
NCBI chr 3:60,721,137...60,795,951
Ensembl chr 3:60,721,135...60,795,951
|
|
G |
Best1 |
bestrophin 1 |
decreases activity |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of BEST1 protein |
CTD |
PMID:19828819 |
|
NCBI chr 1:226,033,146...226,049,893
Ensembl chr 1:226,030,875...226,049,929
|
|
G |
Casp3 |
caspase 3 |
decreases expression |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased expression of CASP3 protein |
CTD |
PMID:21538933 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in increased expression of CCND1 mRNA |
CTD |
PMID:21538933 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Cftr |
CF transmembrane conductance regulator |
multiple interactions decreases activity |
ISO EXP |
5-nitro-2-(3-phenylpropylamino)benzoic acid analog binds to and results in increased activity of CFTR protein; 5-nitro-2-(3-phenylpropylamino)benzoic acid analog binds to and results in increased activity of CFTR protein mutant form; 5-nitro-2-(3-phenylpropylamino)benzoic acid binds to and results in increased activity of CFTR protein; 5-nitro-2-(3-phenylpropylamino)benzoic acid binds to and results in increased activity of CFTR protein mutant form 5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of CFTR protein |
CTD |
PMID:15131065 PMID:15277574 PMID:15389550 PMID:15634668 PMID:15802612 PMID:15857825 |
|
NCBI chr 4:42,693,263...42,860,679
Ensembl chr 4:42,692,836...42,860,676
|
|
G |
Clcn3 |
chloride voltage-gated channel 3 |
decreases activity increases expression multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of CLCN3 protein 5-nitro-2-(3-phenylpropylamino)benzoic acid results in increased expression of CLCN3 mRNA [5-nitro-2-(3-phenylpropylamino)benzoic acid results in increased expression of CLCN3 mRNA] which results in decreased susceptibility to Cisplatin |
CTD |
PMID:17699636 PMID:21538933 |
|
NCBI chr16:32,448,821...32,520,649
Ensembl chr16:32,449,116...32,519,148
|
|
G |
Gpr35 |
G protein-coupled receptor 35 |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid binds to and results in increased activity of GPR35 protein |
CTD |
PMID:20826425 |
|
NCBI chr 9:100,129,428...100,141,269
Ensembl chr 9:100,137,881...100,138,801
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitrites]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide] |
CTD |
PMID:9918806 PMID:19446535 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [TNF protein results in increased phosphorylation of JUN protein] |
CTD |
PMID:9918806 |
|
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [TNF protein promotes the reaction [MAPK1 protein results in increased phosphorylation of ATF2 protein]] |
CTD |
PMID:9918806 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] |
CTD |
PMID:19446535 |
|
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Panx1 |
Pannexin 1 |
decreases activity |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of PANX1 protein |
CTD |
PMID:19023039 |
|
NCBI chr 8:13,567,185...13,606,040
Ensembl chr 8:13,566,739...13,606,040
|
|
G |
Sct |
secretin |
decreases activity |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of SCT protein |
CTD |
PMID:10880878 |
|
NCBI chr 1:214,264,865...214,277,437
Ensembl chr 1:214,264,754...214,265,668
|
|
G |
Slc16a1 |
solute carrier family 16 member 1 |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [SLC16A1 protein results in increased uptake of Butyrates] |
CTD |
PMID:19023563 |
|
NCBI chr 2:207,108,552...207,129,352
Ensembl chr 2:207,108,552...207,128,554
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine] |
CTD |
PMID:27979590 |
|
NCBI chr16:20,297,414...20,307,401
Ensembl chr16:20,297,414...20,307,400
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitrites]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [TNF protein promotes the reaction [MAPK1 protein results in increased phosphorylation of ATF2 protein]]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [TNF protein results in increased phosphorylation of JUN protein]; 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [TNF protein results in increased transport of Chlorides] |
CTD |
PMID:9918806 PMID:10783394 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Vip |
vasoactive intestinal peptide |
multiple interactions |
ISO |
5-nitro-2-(3-phenylpropylamino)benzoic acid promotes the reaction [VIP protein results in increased expression of AQP3 mRNA] |
CTD |
PMID:12542607 |
|
NCBI chr 1:42,169,307...42,177,582
Ensembl chr 1:42,169,501...42,177,582
|
|
|
G |
Adora1 |
adenosine A1 receptor |
multiple interactions |
EXP |
[Dithiothreitol co-treated with Dithionitrobenzoic Acid] inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]; Cadmium Chloride promotes the reaction [Dithionitrobenzoic Acid inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]]; Dithionitrobenzoic Acid inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]; Dithionitrobenzoic Acid promotes the reaction [Cadmium Chloride inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]]; Dithiothreitol inhibits the reaction [Dithionitrobenzoic Acid inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]] |
CTD |
PMID:10413299 |
|
NCBI chr13:51,042,111...51,076,913
Ensembl chr13:51,042,248...51,076,852
|
|
G |
Alb |
albumin |
multiple interactions increases reduction |
ISO |
[ALB protein binds to Docosahexaenoic Acids] inhibits the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to Eicosapentaenoic Acid] inhibits the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to Myristic Acid] promotes the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to Oleic Acid] promotes the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to Palmitic Acid] promotes the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein binds to stearic acid] promotes the reaction [ALB protein results in increased reduction of Dithionitrobenzoic Acid]; [ALB protein modified form binds to Myristic Acid] which results in decreased reduction of Dithionitrobenzoic Acid; [ALB protein modified form binds to Oleic Acid] which results in decreased reduction of Dithionitrobenzoic Acid; [ALB protein modified form binds to Palmitic Acid] which results in decreased reduction of Dithionitrobenzoic Acid; [ALB protein modified form binds to stearic acid] which results in decreased reduction of Dithionitrobenzoic Acid; [Pyruvaldehyde results in increased oxidation of ALB protein] which results in decreased reduction of Dithionitrobenzoic Acid |
CTD |
PMID:25451573 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Mt3 |
metallothionein 3 |
affects metabolic processing |
ISO |
MT3 protein polymorphism affects the metabolism of Dithionitrobenzoic Acid |
CTD |
PMID:14983064 |
|
NCBI chr19:11,324,708...11,326,112
Ensembl chr19:11,324,698...11,326,139
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
multiple interactions |
EXP |
Dithionitrobenzoic Acid inhibits the reaction [PTGR1 protein results in increased reduction of 10-nitro-oleic acid analog]; Dithionitrobenzoic Acid inhibits the reaction [PTGR1 protein results in increased reduction of 15-ketoprostaglandin E2] |
CTD |
PMID:23878198 |
|
NCBI chr 5:76,110,746...76,129,361
Ensembl chr 5:76,110,738...76,129,441
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions affects metabolic processing increases reduction |
ISO EXP |
Dinitrochlorobenzene inhibits the reaction [TXNRD1 protein affects the metabolism of Dithionitrobenzoic Acid]; diphenyleneiodonium inhibits the reaction [TXNRD1 protein affects the metabolism of Dithionitrobenzoic Acid]; Gold Sodium Thiomalate inhibits the reaction [TXNRD1 protein affects the metabolism of Dithionitrobenzoic Acid] TXNRD1 protein results in increased reduction of Dithionitrobenzoic Acid [Dinitrochlorobenzene binds to TXNRD1 protein] inhibits the reaction [TXNRD1 protein results in increased reduction of Dithionitrobenzoic Acid]; Dithionitrobenzoic Acid inhibits the reaction [[TXNRD1 protein co-treated with NADP] results in increased abundance of Superoxides]; Ferrous Compounds inhibits the reaction [TXNRD1 protein results in increased reduction of Dithionitrobenzoic Acid] |
CTD |
PMID:17229725 PMID:20457604 PMID:21172426 |
|
NCBI chr 7:26,946,124...26,984,400
Ensembl chr 7:26,946,125...26,984,400
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
increases reduction |
ISO |
TXNRD2 protein results in increased reduction of Dithionitrobenzoic Acid |
CTD |
PMID:21172426 |
|
NCBI chr11:86,667,994...86,716,063
Ensembl chr11:86,667,997...86,716,254
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
bifenox binds to and results in increased activity of AHR protein |
CTD |
PMID:18835618 |
|
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
bifenox inhibits the reaction [Metribolone results in increased activity of AR protein]; Dihydrotestosterone inhibits the reaction [bifenox results in increased activity of AR protein] |
CTD |
PMID:15064155 PMID:18324785 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
bifenox binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:21115097 |
|
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO |
bifenox results in increased activity of NR1I3 protein |
CTD |
PMID:28927721 |
|
NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
|
|